Cefdinir Suspension |
Omnicef Suspension |
Clinical Trial: Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients with Graft vs. Host Disease
This study has been completed.
|
Purpose
This trial is in high risk patients to determine the safety, tolerance and efficacy of posaconazole (POZ) vs. fluconazole in the prophylaxis against development of invasive fungal infections (IFI).
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Mycoses | Drug: Posaconazole oral suspension | Phase III |
MedlinePlus related topics: Fungal Infections
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Expected Total Enrollment: 600
Study start: February 1998; Study completion: December 2003
This study is designed to determine the safety, tolerance and efficacy of POZ used as prophylaxis of IFI in high-risk subjects with Grade II-IV acute graft vs. host disease (GVHD) or extensive chronic GVHD. The primary objective is to assess the efficacy of SCH56592 vs fluconazole in preventing proven or probable IFI within the time period from randomization to 16 weeks after the start of treatment with study drug.
Eligibility
Ages Eligible for Study: 13 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Hematopoietic progenitor cell transplant subjects with chronic or Grade II-IV acute GVHD being treated with high dose immunosuppressive therapy.
- One of the following to the subject's prior immunosuppressive regimen: (a) at least 1mg per kg per day of methylprednisolone or equivalent, (b) Antithymocyte globulin (ATG) for the therapy of acute GVHD, (c) Tacrolimus, mycophenolate mofetil, or other steroid-sparing immunosuppressive regimen.
Location Information
Arkansas
University of AR for Med. Sciences, Little Rock, Arkansas, United States
California
City of Hope National Medical Center, Duarte, California, 91010, United States
St. Joseph Hospital, Orange, California, 92868-5600, United States
Orange County Children's Hospital, Orange, California, 92868, United States
Colorado
University of Colorado-HSC, Denver, Colorado, 80262, United States
Blood and Marrow Transplant Program - RMCC, Denver, Colorado, 80218, United States
Connecticut
Univ. of Connecticut Health Center, Farmington, Connecticut, 06030, United States
Yale University School of Medicine, New Haven, Connecticut, 06520-8032, United States
Delaware
Christiana Health Care Health Services, Newark, Delaware, 19718, United States
Florida
University of Florida, Gainesville, Florida, 32610-0277, United States
Walt Disney Memorial Cancer Institute, Orlando, Florida, 32804, United States
Univ. of South Florida, Tampa, Florida, United States
Nemours Children's Clinic, Jacksonville, Florida, 32207, United States
Georgia
Emory University BMT Center, Atlanta, Georgia, 30322, United States
BMT Group of Georgia, Atlanta, Georgia, 30342, United States
Illinois
Loyola University, Maywood, Illinois, 60153, United States
Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois, 60612-3813, United States
Indiana
Indiana Blood and Marrow Transplantation, Beech Grove, Indiana, 46107, United States
Kansas
University of Kansas Medical Center, Kansas City, Kansas, 66160, United States
Kentucky
Brown Cancer Center, Louisville, Kentucky, 40202-3229, United States
Louisiana
Louisiana State University Medical Center, Shreveport, Louisiana, 71130, United States
Maryland
Johns Hopkins Hospital Oncology Center, Baltimore, Maryland, 21231, United States
University of Maryland School of Medicine, Baltimore, Maryland, 21201-1595, United States
Massachusetts
Mass General Hospital, Boston, Massachusetts, 02114, United States
Umass Memorial Medical Center, Worcester, Massachusetts, 01655, United States
New England Medical Center, Boston, Massachusetts, 02111, United States
Michigan
Harper Hospital, Detroit, Michigan, 48201, United States
Henry Ford Hospital, Detroit, Michigan, 48202, United States
Minnesota
University of Minnesota Medical Center, Minneapolis, Minnesota, 55455, United States
Missouri
Kansas City Cancer Center, Kansas City, Missouri, 64111, United States
Washington University, St. Louis, Missouri, 631110-1093, United States
Nebraska
University of Nebraska, Omaha, Nebraska, 68198-7680, United States
New Jersey
Hackensack Univ. Medical Center, Hackensack, New Jersey, 07601, United States
New York
North Shore University Hospital, Manhasset, New York, 11030, United States
New York Medical College, Valhalla, New York, 10595, United States
North Carolina
Duke Medical Center, Durham, North Carolina, United States
Ohio
University Hospitals of Cleveland, Cleveland, Ohio, 44106-5089, United States
Jewish Hospital, Cincinnati, Ohio, 45236, United States
Oklahoma
Univ. of Oklahoma Dept of Medicine, Oklahoma City, Oklahoma, 73104, United States
Oregon
Oregon Health Sciences University, Portland, Oregon, 97201, United States
Pennsylvania
University of Penn Cancer Center, Philadelphia, Pennsylvania, 19104-4283, United States
The Western Pennsylvania Hospital BMT Program, Pittsburgh, Pennsylvania, 15224-1791, United States
Jeanes Hospital of TUHS, Philadelphia, Pennsylvania, 19111, United States
South Carolina
University of South Carolina, Columbia, South Carolina, 29203, United States
Texas
Methodist Hospital, Houston, Texas, 77030, United States
MD Anderson Cancer Center, Houston, Texas, 77030, United States
UTHSCSA, San Antonio, Texas, 68284-7881, United States
Baylor University Medical Center-Dallas, Dallas, Texas, 75246, United States
Texas Transplant Institute, San Antonio, Texas, 78229, United States
Washington
VA Puget Sound Health Care System, Seattle, Washington, 98108-1595, United States
West Virginia
West Virginia University, Morgantown, West Virginia, 26506, United States
Wisconsin
Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States
Argentina
Instituto Alexander Fleming, Buenos Aires, Argentina
Fundaleu, Buenos Aires, Argentina
Australia
St. Vincent Hospital, Sydney, Australia
Royal Melbourne Hospital, Melbourne, Australia
Royal Brisbane Hospital, Brisbane, Australia
Alfred Hospital, Prahran, Australia
Austria
University Clinic for Hematology, Vienna, Austria
University Clinic for Internal Medicine Graz, Graz, Austria
Brazil
Hospital Das Clinicas Da UFMG, Belo Horizonte, Brazil
Hospital Das Clinicas Da Fmusp, Sao Paulo, Brazil
Instituto Nacional De Cancer, Rio de Janeiro, Brazil
Comite De Etica Em Pesquisa Em Seres, Curitiba, Brazil
Canada
Winnipeg Health Sciences Center, Winnipeg, Canada
Ottawa Hospital-General Campus, Ottawa, Canada
Royal Victoria Hospital, Montreal, Canada
Hospital Maisonneuve Rosemont, Montreal, Canada
Princess Margaret Hospital, Toronto, Canada
McMaster Hospital, Hamilton, Canada
Tom Baker Cancer Center, Calgary, Canada
Queen Elizabeth II Health Sciences Center, Halifax, Canada
Czech Republic
University Hospital Motol, Prague, Czech Republic
Institue of Hematology and Blood Transfusion, Prague, Czech Republic
Denmark
Hematological Dept. 4042, Copenhagen, Denmark
Finland
Helsinki University Central Hospital, Helsinki, Finland
France
Institut Paoli-Calmettes, Marseille, France
Hopital Henri Mondor, Creteil, France
Hopital Hotel Dieu, Nantes, France
Institut Gustave Roussy, Villejuif, France
Hoptial Edourard Herriot, Lyon, France
C.H.R.U. de Lillie, Hospital Claude Huriez, Lille, France
Hopital de Hautepierre, Strasbourg, France
C.H.U. Hopital De La Miletrie, Poitiers, France
Germany
Universitatsklinik Carl Gustart Caros, Dresden, Germany
III. Medizinische Klinik und, Mainz, Germany
Deutsche Klinik Fuer Diagnostik-DKD, Wiesbaden, Germany
Greece
Evangelimos Hospital, Athens, Greece
Hungary
National Institute for Hematology and Immunology, Budapest, Hungary
Italy
II Divisione di Ematologia, Genova, Italy
Divisione di Ematologia, Pavia, Italy
Divisone di Ematlogia, Palermo, Italy
Ospadali Riuniti Centro, Reggio Calabria, Italy
Ospedale La Maddalena, Palermo, Italy
Oppedale Civile Centro Trapiati, Pescara, Italy
Mexico
Hospital de Especialidades, Mexico City, Mexico
Centro Medico National 20 de Mexico City, Mexico City, Mexico
Netherlands
University Hospital Utrecht, Utrecht, Netherlands
University Hospital Nijmegen, Nijmegen, Netherlands
Peru
Hospital Edgardo Rebagliati, Lima, Peru
Poland
Department of Hematology and BMT, Katowice, Poland
Portugal
Unidade De Transplantacao de Lisboa, Lisboa, Portugal
Instituto Portugues de Oncologia do Porto, Porto, Portugal
Saudi Arabia
Section of Infectious Diseases, Riyadh, Saudi Arabia
Singapore
Singapore General Hospital, Singapore, Singapore
South Africa
University of Cape Town, Cape Town, South Africa
Spain
Hospital de la Princesa, Madrid, Spain
Hospital Marques de Valdecilla, Santander, Spain
Hospital Universitario Virgen Del Rocio, Sevilla, Spain
Hospital Clinic I Provincial, Barcelona, Spain
Hospital Universitario, Valencia, Spain
Hospital Reina Sofia, Cordoba, Spain
Hospital Universitario de Salamanca, Salamanca, Spain
Institut Catala Doncologia, Barcelona, Spain
Sweden
Sahlgrenska University Hospital, GOTHENBURG, Sweden
Huddinge University Hospital, Stockholm, Sweden
Akademiska Hospital, Uppsala, Sweden
Switzerland
Kantonsspital Basel, Basel, Switzerland
United Kingdom
Hammersmith Hospital, London, United Kingdom
Royal London Hospital, London, United Kingdom
Hematology University Hosptial of Wales, Wales, United Kingdom
John Radcliffe Hospital, Headington, United Kingdom
More Information
Record last reviewed: July 2004
Last Updated: October 13, 2004
Record first received: May 1, 2002
ClinicalTrials.gov Identifier: NCT00034645
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Cefdinir Suspension (Drug Digest)
- Omnicef Suspension (Drug Digest)

Not Signed In -

